EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Prevalence of opioid-induced adverse events across opioids commonly used for analgesic treatment in Japan: a multicenter prospective longitudinal study

Yusuke Hiratsuka, Keita Tagami, Akira Inoue, Mamiko Sato, Yasufumi Matsuda, Kazuhiro Kosugi, Emi Kubo, Maika Natsume, Hiroto Ishiki, Sayaka Arakawa, Masaki Shimizu, Naosuke Yokomichi und 11 weitere

Supportive Care in Cancer · 2023

DOI: 10.1007/s00520-023-08099-2 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Supportive Care in Cancer, 2023. Verfasst von Yusuke Hiratsuka und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Palliative Medicine, Takeda General Hospital, Aizu Wakamatsu, Japan. hiratsuka.med.t@gmail.com. Hauptthemen laut MEDLINE: Cancer Pain, Tramadol, Delirium. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Cancer Center Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Although opioids have been shown to be effective for cancer pain, opioid-induced adverse events (AEs) are common. To date, little is known about the differences in risks of AEs by opioid type. This study was performed to compare the prevalence of AEs across opioids commonly used for analgesic treatment in Japan.

Methods

This study was conducted as a preplanned secondary analysis of a multicenter prospective longitudinal study of inpatients with cancer pain who received specialized palliative care for cancer pain relief. We assessed daily AEs until termination of follow-up. We rated the severity of AEs based on the Common Terminology Criteria for Adverse Events version 5.0. We computed adjusted odds ratios for each AE (constipation, nausea and vomiting, delirium, and drowsiness) with the following variables: opioid, age, sex, renal dysfunction, and primary cancer site.

Results

In total, 465 patients were analyzed. Based on the descriptive analysis, the top four most commonly used opioids were included in the analysis: oxycodone, hydromorphone, fentanyl, and tramadol. With respect to the prevalence of AEs among all analyzed patients, delirium ( n = 25, 6.3%) was the most frequent, followed by drowsiness ( n = 21, 5.3%), nausea and vomiting ( n = 19, 4.8%), and constipation ( n = 28, 4.6%). The multivariate logistic analysis showed that no single opioid was identified as a statistically significant independent predictor of any AE.

Conclusion

There was no significant difference in the prevalence of AEs among oxycodone, fentanyl, hydromorphone, and tramadol, which are commonly used for analgesic treatment in Japan.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer PainTramadolDeliriumHumansAnalgesics, OpioidOxycodoneHydromorphoneProspective StudiesJapanPrevalenceLongitudinal StudiesFentanylConstipationNauseaVomiting

Stichwörter der Autor:innen

Advanced cancerAdverse eventOpioidSpecialized palliative care

Substanzen

Analgesics, OpioidOxycodoneHydromorphoneTramadolFentanyl

Autor:innen und Institutionen

  • Department of Palliative Medicine, Takeda General Hospital, Aizu Wakamatsu, Japan. hiratsuka.med.t@gmail.com.
  • Department of Palliative Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan. hiratsuka.med.t@gmail.com.
  • Department of Palliative Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Department of Palliative Medicine, National Cancer Center Hospital East, Kashiwa, Japan.
  • Department of Palliative Medicine, National Cancer Center Hospital, Tokyo, Japan.
  • Department of Palliative Care, Kyoto-Katsura Hospital, Kyoto, Japan.

Förderung

  • National Cancer Center Japan

Zitieren

APA

Hiratsuka, Y., Tagami, K., Inoue, A., Sato, M., Matsuda, Y., Kosugi, K., Kubo, E., Natsume, M., Ishiki, H., Arakawa, S., Shimizu, M., Yokomichi, N., Chiu, S. W., Shimoda, M., Hirayama, H., Nishijima, K., Ouchi, K., Shimoi, T., Shigeno, T., …, & Satomi, E. (2023). Prevalence of opioid-induced adverse events across opioids commonly used for analgesic treatment in Japan: a multicenter prospective longitudinal study. Supportive Care in Cancer. https://doi.org/10.1007/s00520-023-08099-2

Vancouver

Hiratsuka Y, Tagami K, Inoue A, Sato M, Matsuda Y, Kosugi K, et al. Prevalence of opioid-induced adverse events across opioids commonly used for analgesic treatment in Japan: a multicenter prospective longitudinal study. Supportive Care in Cancer. 2023. doi:10.1007/s00520-023-08099-2

BibTeX
@article{Hiratsuka2023,
  author = {Hiratsuka, Yusuke and Tagami, Keita and Inoue, Akira and Sato, Mamiko and Matsuda, Yasufumi and Kosugi, Kazuhiro and Kubo, Emi and Natsume, Maika and Ishiki, Hiroto and Arakawa, Sayaka and Shimizu, Masaki and Yokomichi, Naosuke and Chiu, Shih-Wei and Shimoda, Mayu and Hirayama, Hideyuki and Nishijima, Kaoru and Ouchi, Kota and Shimoi, Tatsunori and Shigeno, Tomoko and Yamaguchi, Takuhiro and Miyashita, Mitsunori and Morita, Tatsuya and Satomi, Eriko},
  title = {Prevalence of opioid-induced adverse events across opioids commonly used for analgesic treatment in Japan: a multicenter prospective longitudinal study},
  journal = {Supportive Care in Cancer},
  year = {2023},
  doi = {10.1007/s00520-023-08099-2}
}
Kostenlos starten →